Home › Funds › ACORN CAPITAL ADVISORS, LLC › CGON
ACORN CAPITAL ADVISORS, LLC position in CGON
CG ONCOLOGY INC · Health Care
ACORN CAPITAL ADVISORS, LLC reported holding 1,131,500 shares of CGON (CG ONCOLOGY INC) in its Q2 2026 13F filing — a position valued at US$80.4M, representing 21.94% of its reported portfolio and ranking #1 among its reported holdings. ACORN CAPITAL ADVISORS, LLC has disclosed CGON holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ACORN CAPITAL ADVISORS, LLC's CGON position evolved
ACORN CAPITAL ADVISORS, LLC first disclosed a stake in CGON in Q4 2024 at 1,131,501 shares (US$32.5M). The position peaked in Q2 2026 at 1,131,500 shares, worth US$80.4M. Across 7 filings, ACORN CAPITAL ADVISORS, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 1,131,500 shares valued at US$80.4M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 1.13M | $32.45M | New |
| Q1 2025 | 1.13M | $27.72M | Hold |
| Q2 2025 | 1.13M | $29.42M | Hold |
| Q3 2025 | 1.13M | $45.58M | Hold |
| Q4 2025 | 1.13M | $46.98M | Hold |
| Q1 2026 | 1.13M | $76.58M | Hold |
| Q2 2026 | 1.13M | $80.39M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CGON and 13F data
CGON (CG ONCOLOGY INC) is a Health Care company. 52 other funds we track also report a position in CGON — the largest reported positions include RTW INVESTMENTS, LP (US$605.0M), Decheng Capital LLC (US$452.7M), TCG Crossover Management, LLC (US$260.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CGON
- RTW INVESTMENTS, LP 8.51M sh · $604.96M · Q2 2026
- Decheng Capital LLC 6.37M sh · $452.71M · Q2 2026
- TCG Crossover Management, LLC 3.67M sh · $260.77M · Q2 2026
- Foresite Capital Management VI LLC 2.37M sh · $168.36M · Q2 2026
- Seven Fleet Capital Management LP 1.89M sh · $134.02M · Q2 2026
- DV Trading LLC 1.44M sh · $102.27M · Q2 2026
- Avidity Partners Management LP 1.40M sh · $99.40M · Q2 2026
- Foresite Capital Management V, LLC 1.08M sh · $76.67M · Q2 2026
- Logos Global Management LP 1.00M sh · $71.05M · Q2 2026
- ORBIMED ADVISORS LLC 972.80K sh · $69.12M · Q2 2026
- Jefferies Financial Group Inc. 769.95K sh · $54.70M · Q2 2026
- EcoR1 Capital, LLC 561.50K sh · $39.89M · Q2 2026
More on ACORN CAPITAL ADVISORS, LLC
FAQ
How long has ACORN CAPITAL ADVISORS, LLC held CGON?
ACORN CAPITAL ADVISORS, LLC has disclosed CGON holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
What is ACORN CAPITAL ADVISORS, LLC's current position in CGON?
As of Q2 2026, ACORN CAPITAL ADVISORS, LLC holds 1.13M shares of CGON (CG ONCOLOGY INC), valued at $80.39M, representing 21.94% of its reported portfolio and ranking #1.
Has ACORN CAPITAL ADVISORS, LLC been buying or selling CGON?
In the latest 13F filing (Q2 2026), ACORN CAPITAL ADVISORS, LLC held unchanged its position in CGON. The position peaked in Q2 2026 at 1.13M shares.
Which other funds hold CGON?
Other major institutional holders of CGON include RTW INVESTMENTS, LP, Decheng Capital LLC, TCG Crossover Management, LLC, among 52 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.